Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation
Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation
复制标题
Atxn2-CAG100 敲入小鼠的产生揭示了由于早期 Nat8l 失调导致的 N-乙酰天冬氨酸生产缺陷
DOI:
10.1016/j.nbd.2019.104559
复制
发表时间:
2019
影响因子:
6.1
通讯作者:
Auburger G
中科院分区:
文献类型:
--
作者:
Sen NE;Canet-Pons J;Halbach MV;Arsovic A;Pilatus U;Chae WH;Kaya ZE;Seidel K;Rollmann E;Mittelbronn M;Meierhofer D;De Zeeuw CI;Bosman LWJ;Gispert S;Auburger G
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative disorder caused by CAG-expansion mutations in theATXN2gene, mainly affecting motor neurons in the spinal cord and Purkinje neurons in the cerebellum. While the large expansions were shown to cause SCA2, the intermediate length expansions lead to increased risk for several atrophic processes including amyotrophic lateral sclerosis and Parkinson variants, e.g. progressive supranuclear palsy. Intense efforts to pioneer a neuroprotective therapy for SCA2 require longitudinal monitoring of patients and identification of crucial molecular pathways. The ataxin-2 (ATXN2) protein is mainly involved in RNA translation control and regulation of nutrient metabolism during stress periods. The preferential mRNA targets of ATXN2 are yet to be determined. In order to understand the molecular disease mechanism throughout different prognostic stages, we generated anAtxn2-CAG100-knock-in (KIN) mouse model of SCA2 with intact murine ATXN2 expression regulation. Its characterization revealed somatic mosaicism of the expansion, with shortened lifespan, a progressive spatio-temporal pattern of pathology with subsequent phenotypes, and anomalies of brain metabolites such asN-acetylaspartate (NAA), all of which mirror faithfully the findings in SCA2 patients. Novel molecular analyses from stages before the onset of motor deficits revealed a strong selective effect of ATXN2 onNat8lmRNA which encodes the enzyme responsible for NAA synthesis. This metabolite is a prominent energy store of the brain and a well-established marker for neuronal health. Overall, we present a novel authentic rodent model of SCA2, where in vivo magnetic resonance imaging was feasible to monitor progression and where the definition of earliest transcriptional abnormalities was possible. We believe that this model will not only reveal crucial insights regarding the pathomechanism of SCA2 and other ATXN2-associated disorders, but will also aid in developing gene-targeted therapies and disease prevention.
登录
查看更多内容
DOI:
10.1007/s12031-012-9949-4
发表时间:
2013-09
期刊:
Journal of molecular neuroscience : MN
影响因子:
--
作者:
Drost J;Nonis D;Eich F;Leske O;Damrath E;Brunt ER;Lastres-Becker I;Heumann R;Nowock J;Auburger G
通讯作者:
Auburger G
影响因子:
5
作者:
U. Rüb;C. Schultz;K. Tredici;K. Gierga;G. Reifenberger;R. D. Vos;C. Seifried;H. Braak;G. Auburger
通讯作者:
G. Auburger
影响因子:
4.5
作者:
Al-Ramahi I;Pérez AM;Lim J;Zhang M;Sorensen R;de Haro M;Branco J;Pulst SM;Zoghbi HY;Botas J
通讯作者:
Botas J
影响因子:
3.3
作者:
A. Antenora;D. Bruzzese;M. Lieto;A. Roca;Maria Teresa Florio;S. Peluso;F. Saccà;G. De Michele;F. Santorelli;A. Filla
通讯作者:
A. Filla
影响因子:
3.5
作者:
Di Fabio, Roberto;Santorelli, Filippo;Casali, Carlo
通讯作者:
Casali, Carlo